Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LYSERGIDE vs MACITENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LYSERGIDE vs MACITENTAN: Safety Overview

Metric LYSERGIDE MACITENTAN
Total FAERS Reports 289 45,325
Deaths Reported 57 9,886
Death Rate 19.7% 21.8%
Hospitalizations 144 24,183
Average Patient Age 29.3 yrs 61.5 yrs
% Female Patients 26.6% 74.3%
FDA Approval Date N/A Apr 18, 2023
Manufacturer N/A Actelion Pharmaceuticals US, Inc.
Route N/A ORAL
Marketing Status N/A Prescription